Why You’re Not Losing Weight on Ozempic

In this episode, I explain why some patients do not lose weight right away on GLP 1 medications like Ozempic, Wegovy, Mounjaro, and ZepBound. I start with Priscilla, a patient taking 7.5 mg of tirzepatide who lost zero pounds after one month. She was frustrated because someone else on the same medication lost eight pounds in the same amount of time. That comparison is common, but it does not tell the whole story. I break down how GLP 1 medications work. These medications help reduce appetite in the brain and help patients feel full sooner by affecting the stomach. But not every body responds the same way. Genetics, receptor differences, diabetes status, sex, environment, eating habits, and daily routines can all influence weight loss. I also explain why medication alone is not enough. Successful weight loss usually requires regular follow up, dose adjustments when appropriate, and intensive behavioral changes. Monthly visits matter because they help us review what happened over the previous 30 days, not just what happened yesterday. The scale is not a judgment. It is information. It helps us ask better questions. Did your eating pattern change? Were you staying within your calorie goals? Was emotional eating a factor? Did your environment support your weight loss, or work against it? This episode is also about physician patient allyship. If you are stalling on Ozempic, Wegovy, Mounjaro, or ZepBound, the answer is not to give up. The answer is to review the dose, the habits, the follow up plan, the support system, and the behavioral changes that make the medication work better. The main message is simple: if the scale is not moving, that does not mean you failed. It means we need to look deeper, adjust the plan, and keep working together.Questions for Dr. Takem and the team💡 Start your journey today with Maryland Primary Care & WellnessBook your consultation: https://www.maryland-primarycare.com/